These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38018845)

  • 1. A Systematic Review of Clozapine Concentration-Dose Ratio from Therapeutic Drug Monitoring Studies in Children and Adolescents Treated with Clozapine for Mental Disorders.
    Jiménez-Fernández S; Gurpegui M; Correll CU; de Leon J; Schoretsanitis G
    Ther Drug Monit; 2024 Apr; 46(2):170-180. PubMed ID: 38018845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine Metabolism in East Asians and Caucasians: A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review.
    Ruan CJ; Zang YN; Wang CY; Cheng YH; Sun C; Spina E; de Leon J
    J Clin Psychopharmacol; 2019; 39(2):135-144. PubMed ID: 30811372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using therapeutic drug monitoring to personalize clozapine dosing in Asians.
    de Leon J; Schoretsanitis G; Kane JM; Ruan CJ
    Asia Pac Psychiatry; 2020 Jun; 12(2):e12384. PubMed ID: 32119764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder.
    Rafizadeh R; Sooch A; Risi A; Bihelek N; Kanegawa K; Barr AM; White RF; Schütz CG; Bousman CA
    J Psychopharmacol; 2024 Jun; 38(6):526-531. PubMed ID: 38520287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed.
    Schoretsanitis G; Smith RL; Molden E; Solismaa A; Seppälä N; Kopeček M; Švancer P; Olmos I; Vázquez M; Iglesias-Garcia C; Iglesias-Alonso A; Spina E; de Leon J
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):140-147. PubMed ID: 33587398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoring.
    Jia F; Zang YN; Ruan CJ; Chi L; Zhuang HY; Wan Z; Yang Q; de Leon J
    Schizophr Res; 2024 Jun; 268():308-311. PubMed ID: 37775404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics.
    de Leon J
    Neuropharmacology; 2020 May; 168():107656. PubMed ID: 31150659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study.
    Suhas S; Kumar V; Damodharan D; Sharma P; Rao NP; Varambally S; Venkatasubramanian G; Murthy P; Gangadhar BN
    Schizophr Res; 2020 Aug; 222():195-201. PubMed ID: 32518001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Asian Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Overview.
    de Leon J; Rajkumar AP; Kaithi AR; Schoretsanitis G; Kane JM; Wang CY; Tang YL; Lin SK; Hong KS; Farooq S; Ng CH; Ruan CJ; Andrade C
    Indian J Psychol Med; 2020; 42(1):4-10. PubMed ID: 31997860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
    Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
    J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unanticipated plasma concentrations in two clozapine-treated patients.
    Alfaro CL; McClure RK; Vertrees JE; Benavides R
    Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.
    Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH
    J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration.
    Liu T; Gao P; Xie C; Zhang H; Shi Z; Chen R
    BMC Psychiatry; 2023 Aug; 23(1):596. PubMed ID: 37582705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition.
    Schoretsanitis G; Anıl Yağcıoğlu AE; Ruan CJ; Eap CB; Molden E; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Olmos I; Every-Palmer S; Procyshyn RM; Rohde C; Satish S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; de Leon J
    Schizophr Res; 2024 Jun; 268():302-307. PubMed ID: 37268453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice.
    Wohkittel C; Gerlach M; Taurines R; Wewetzer C; Unterecker S; Burger R; Schreck D; Mehler-Wex C; Romanos M; Egberts K
    J Neural Transm (Vienna); 2016 Aug; 123(8):1021-31. PubMed ID: 27221285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Prevalence of Clozapine Phenotypic Poor Metabolizers in 4 Asian Samples: They Ranged Between 2% and 13.
    Ruan CJ; Wang CY; Tang YL; Lin SK; Lee ST; Hong KS; Rajkumar AP; Jacob KS; de Leon J
    J Clin Psychopharmacol; 2019; 39(6):644-648. PubMed ID: 31688448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations.
    Augustin M; Schoretsanitis G; Pfeifer P; Gründer G; Liebe C; Paulzen M
    Schizophr Res; 2019 Aug; 210():143-148. PubMed ID: 31182321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.